{{Rsnum
|rsid=2003813
|Gene=APOL2
|Chromosome=22
|position=36232947
|Orientation=minus
|GMAF=0.186
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=APOL2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 54.7 | 45.3
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 15.8 | 84.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|18632255|OA=1
}} [[rs9610449]] schizophrenia (377 families, 1161 genotyped members and 647 genotyped affected in total) [[rs9610449]] and [[rs6000200]] associated with risk for schizophrenia in African-Americans. In the combined (AA and EA) sample, two SNPs, [[rs2003813]] and [[rs2157249]]

{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}